- Home
- NKTX vs ARAY Comparison
NKTX vs ARAY Comparison
Compare NKTX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- ARAY
- Stock Information
- Founded
- NKTX 2015
- ARAY 1990
- Country
- NKTX United States
- ARAY United States
- Employees
- NKTX N/A
- ARAY N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- NKTX Health Care
- ARAY Health Care
- Exchange
- NKTX Nasdaq
- ARAY Nasdaq
- Market Cap
- NKTX 170.8M
- ARAY 180.0M
- IPO Year
- NKTX 2020
- ARAY 2007
- Fundamental
- Price
- NKTX $2.47
- ARAY $2.24
- Analyst Decision
- NKTX Strong Buy
- ARAY Strong Buy
- Analyst Count
- NKTX 5
- ARAY 1
- Target Price
- NKTX $15.20
- ARAY $9.00
- AVG Volume (30 Days)
- NKTX 1.5M
- ARAY 669.1K
- Earning Date
- NKTX 11-07-2024
- ARAY 01-29-2025
- Dividend Yield
- NKTX N/A
- ARAY N/A
- EPS Growth
- NKTX N/A
- ARAY N/A
- EPS
- NKTX N/A
- ARAY N/A
- Revenue
- NKTX N/A
- ARAY $444,204,000.00
- Revenue This Year
- NKTX N/A
- ARAY $6.64
- Revenue Next Year
- NKTX N/A
- ARAY $5.69
- P/E Ratio
- NKTX N/A
- ARAY N/A
- Revenue Growth
- NKTX N/A
- ARAY N/A
- 52 Week Low
- NKTX $2.08
- ARAY $1.40
- 52 Week High
- NKTX $16.24
- ARAY $2.99
- Technical
- Relative Strength Index (RSI)
- NKTX 50.49
- ARAY 60.03
- Support Level
- NKTX $2.19
- ARAY $2.04
- Resistance Level
- NKTX $2.70
- ARAY $2.34
- Average True Range (ATR)
- NKTX 0.15
- ARAY 0.15
- MACD
- NKTX 0.03
- ARAY 0.03
- Stochastic Oscillator
- NKTX 54.90
- ARAY 82.76
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.